Showing 1151-1160 of 21421 results for "".
- Imaging-Guided Tape Stripping Standardizes Molecular Profiling in Pediatric Atopic Dermatitishttps://reachmd.com/news/imaging-guided-tape-stripping-standardizes-molecular-profiling-in-pediatric-atopic-dermatitis/2487887/A minimally invasive, imaging-guided tape-stripping technique may provide a standardized method for molecular profiling and treatment monitoring in pediatric atopic dermatitis (AD), according to findings published online ahead of print in the
- Nutrafol Study Reports Improved Hair Growth Rate and Scalp Coverage in Womenhttps://reachmd.com/news/nutrafol-study-reports-improved-hair-growth-rate-and-scalp-coverage-in-women/2487855/A new peer-reviewed study published in Dermatology and Therapy reported significant improvements in multiple objective measures of hair growth among women using Nutrafol Hair Growth Nutraceuticals over a 6-month treatment period. The prospective, open-label, randomized study enrol
- PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine Shows Phase 1 Immunogenicityhttps://reachmd.com/news/pd-1-enhanced-hiv-1-therapeutic-dna-vaccine-shows-phase-1-immunogenicity/2487838/Key Takeaways This first-in-human, randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial evaluated ICVAX in adults with HIV-1 on ART at Shenzhen Third People’s Hospital. Treatment-related adverse events occurred in 83.3% of ICVAX
- Guideline-Based Management Limits Testing and Identifies Risk Factors for Chronic Urticaria in Childrenhttps://reachmd.com/news/guideline-based-management-limits-testing-and-identifies-risk-factors-for-chronic-urticaria-in-children/2487889/Most children presenting with a first episode of acute urticaria (AU) recover with conservative, guideline-based management and require little diagnostic testing, according to a prospective cohort study published in Pediatric Allergy, Immunology, and Pulmonolog
- Zasocitinib Demonstrates Strong Week 16 Responses Across High-Impact Psoriasis Siteshttps://reachmd.com/news/zasocitinib-demonstrates-strong-week-16-responses-across-high-impact-psoriasis-sites/2487716/Takeda announced new secondary analyses from its pivotal Phase 3 LATITUDE PsO 3001 and 3002 trials showing that the investigational oral TYK2 inhibitor zasocitinib (TAK-279) achieved high rates of skin clearance in adults with moderate-to-severe plaque psoriasis a
- Sleep Apnea Linked to Higher Incident Glaucoma in Real-World Studyhttps://reachmd.com/news/sleep-apnea-glaucoma-real-world-study/2487817/Key Takeaways Adults evaluated for OSA showed higher later incident glaucoma than sleep-tested controls without OSA. Glaucoma incidence increased stepwise from controls to OSA without a PAP record and was highest in the PAP-record subgroup. Th
- Text Messaging Intervention Improves Cardiovascular Risk Behaviors in PsO Trialhttps://reachmd.com/news/text-messaging-intervention-improves-cardiovascular-risk-behaviors-in-pso-trial/2487819/A structured text messaging intervention was shown to improve patient activation and several cardiovascular risk behaviors among adults with psoriasis, according to new findings published in JAMA Dermatology.
- Ramucirumab Plus Docetaxel Shows Phase II Activity in Gastric Cancerhttps://reachmd.com/news/ramucirumab-plus-docetaxel-shows-phase-ii-activity-in-gastric-cancer/2487782/Key Takeaways The combination was associated with measurable activity, with disease control reported in nearly three quarters of patients. The findings came from a multicenter, single-arm phase II trial of 35 patients who were refractory or intolerant
- Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edemahttps://reachmd.com/news/interleukin-6-inhibition-with-vamikibart-for-uveitic-macular-edema/2487788/Key Takeaways Intravitreal vamikibart was associated with week 12 improvement in visual acuity and retinal thickness across all three dose groups. Ocular adverse events were reported in 19 of 37 participants, with one unrelated serious event, one treat
- IVUS Guidance In Complex High-Risk PCI Fails To Lower TVFhttps://reachmd.com/news/ivus-guidance-in-complex-high-risk-pci-fails-to-lower-tvf/2487783/Key Takeaways Target-vessel failure occurred more often numerically with IVUS guidance, and a lower primary-endpoint risk was not reported with that strategy. IVUS-guided procedures lasted longer and more often included balloon angioplasty after stent